National Comprehensive Cancer Network



About NCCN

Venous Thromboembolic Disease Panel - Disclosures as of 5/22/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Paula L. Bockenstedt, MD

None

None

None

None

8/20/2012

Spero R. Cataland, MD

None

Amgen Inc.;
Bayer HealthCare;
GlaxoSmithKline

None

None

8/16/2012

Carolyn Chesney, MD

None

None

None

None

10/1/2012

Charles Eby, MD

Siemens Medical Solutions Diagnostics

Bryan Cave law firm;
International Laboratory

None

None

8/21/2012

John Fanikos, RPh, MBA

None

None

None

None

10/15/2012

Annemarie E. Fogerty, MD

None

None

None

None

6/25/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Shuwei Gao, MD

None

None

None

None

9/6/2012

Samuel Z. Goldhaber, MD

Daiichi- Sankyo Co.;
Eisai Inc.;
Johnson & Johnson;
EKOS;
sanofi-aventis U.S.

Baxter International Inc.;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Daiichi- Sankyo Co.;
Eisai Inc.;
Merck & Co., Inc.;
Portola;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

8/20/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Hani Hassoun, MD

None

Ortho Biotech Products, L.P.

None

None

8/18/2012

Paul Hendrie, MD

None

None

None

None

7/31/2012

Bjorn Holmstrom, MD

None

None

None

None

8/20/2012

Nicole Kuderer, MD, MS

;
sanofi-aventis U.S.

Daiichi- Sankyo Co.

None

None

3/7/2012

Jason T. Lee, MD

None

None

None

None

10/19/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Nicole McMillian, MS

None

None

None

None

3/27/2013

Michael M. Millenson, MD, FACP

None

None

None

None

2/22/2013

Maoko Naganuma, MSc

None

None

None

None

2/28/2013

Anne T. Neff, MD

None

Jannsen Pharmaceutica Products, LP

None

None

10/1/2012

Thomas L. Ortel, MD, PhD

Eisai Inc.;
GlaxoSmithKline;
sanofi-aventis U.S.

Boehringer Ingelheim GmbH

None

None

10/24/2011

Rita Paschal, MD

None

None

None

None

2/19/2013

Tanya Siddiqi, MD

None

None

None

None

6/26/2012

Judy L. Smith, MD, FACS

None

None

None

None

10/9/2012

Michael B. Streiff, MD, FACS

Bristol-Myers Squibb Company;
Eisai Inc.;
Jannsen Pharmaceutica Products, LP

Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

Eisai Inc.

8/18/2012

Gary C. Yee, PharmD, FCCP, BCOP

None

Millennium Pharmaceuticals, Inc.

None

None

9/26/2012

Anaadriana Zakarija, MD

None

None

None

None

11/4/2011

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved